As the U.S. grapples with a growing shortage of commercial truck drivers, industry leaders are pointing to an unexpected culprit: outdated federal marijuana regulations. According to multiple national trucking associations, positive cannabis test results—along with strict federal drug testing rules—are sidelining thousands of otherwise qualified drivers, contributing to supply chain delays and labor shortages across the country.
Under current federal law, cannabis remains a Schedule I drug, and the U.S. Department of Transportation (DOT) prohibits any safety-sensitive workers, including commercial drivers, from using marijuana. This includes not only cannabis containing THC, but also CBD products that may contain trace amounts of THC. Drivers are subject to random drug tests, pre-employment screenings, and mandatory testing after accidents or violations. A single positive result—even in a state where cannabis is legal—can lead to suspension, job loss, and placement in a federal return-to-duty program.
The issue isn’t that drivers are showing up to work impaired—it’s that THC metabolites can stay in the body for weeks after use. Urine-based drug tests can detect past cannabis use long after any intoxicating effects have worn off. That means drivers can test positive even if they consumed cannabis legally and responsibly during their time off.
According to data from the Federal Motor Carrier Safety Administration’s Drug & Alcohol Clearinghouse, over 100,000 commercial drivers have been removed from the workforce since the program’s launch in 2020 due to positive marijuana tests. Of those, only about 30% have completed the return-to-duty process and resumed driving. That leaves a significant number of skilled drivers on the sidelines during a time when the trucking industry is already struggling to fill vacancies.
Industry groups like the American Trucking Associations are calling for reform. They’re not asking to allow impaired driving—instead, they want updated testing methods that can distinguish between recent use and past use. Some have pushed for the adoption of oral fluid testing or impairment detection technology that measures actual cognitive function, rather than residual traces in urine.
The timing is critical. The trucking industry is short an estimated 80,000 drivers, and that gap is expected to grow. With e-commerce booming and infrastructure demands on the rise, supply chains rely on a steady flow of commercial drivers. Restrictive cannabis testing policies, especially in legal states, are starting to clash with workforce realities.
Meanwhile, public support for cannabis legalization continues to grow. As of 2024, 24 states have legalized adult-use marijuana, and 38 allow medical use. But federal laws haven’t kept pace, creating confusion and costly setbacks for businesses operating across state lines.
For truckers, the risk is high. One mistake—even using CBD oil that contains more THC than advertised—can result in career-ending consequences. The lack of legal protections also prevents workers from using medical cannabis to manage conditions like chronic pain, anxiety, or PTSD.
Trucking employers and policymakers are now facing a critical question: should outdated cannabis testing policies continue to push experienced drivers out of the workforce, even when no impairment is involved? As the federal government considers cannabis rescheduling, industry leaders hope reforms will finally bring clarity, fairness, and a science-based approach to drug testing.
For more on topics like these, check this link out MAINE LAWMAKERS MOVE PSILOCYBIN LEGALIZATION FORWARD DESPITE SPLIT OPINIONS
